RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM

Losartan potassium, a highly effective blood pressure lowering agent, has widely used for treatment of hypertension. Simple, economic, selective, and precise and stability indicating HPLC method has been developed and validated for analysis of losartan potassium in bulk drug and formulation dosage f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutical sciences and research 2016-06, Vol.7 (6), p.2343-2343
Hauptverfasser: Mohammed, Amna B W E, Rudwan, Elsadig H
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2343
container_issue 6
container_start_page 2343
container_title International journal of pharmaceutical sciences and research
container_volume 7
creator Mohammed, Amna B W E
Rudwan, Elsadig H
description Losartan potassium, a highly effective blood pressure lowering agent, has widely used for treatment of hypertension. Simple, economic, selective, and precise and stability indicating HPLC method has been developed and validated for analysis of losartan potassium in bulk drug and formulation dosage form. In order to optimize more one response at time, the chemo metric approach which includes 2 super( 3) factorial design at two level with three factors was set up to standardize the chromatographic condition. The mobile phase was 40:60 ACN: Buffer consist of 0.05% of orthophosphoric acid and 0.05% Triethylamine at flow rate 1.0ml/minute the eluent was monitored at 225nm. The calibration plots constructed using the concentration of 6.4 to 9.6 mu g/ml (80-120%) with r super( 2) =0.999, recovery =99.44% was indicative of accuracy of proposed method. The precision was calculated as repeatability, intraday for the drug.
doi_str_mv 10.13040/IJPSR.0975-8232.7(6).2343-51
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808729911</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808729911</sourcerecordid><originalsourceid>FETCH-LOGICAL-p118t-34b33beafe014dba873dc6af91e227445553f62f849dc9ec1ba65599d36b6bb93</originalsourceid><addsrcrecordid>eNo9j8tOwzAQRS0kJKrSf_AGqSwSYjsvL03itkZOHMVuJVZVHo4EKrSQ9nP4V1wenc1Ic-89VwPAHQp8RIIweBBPla79gCaRl2KC_WQe3_uYhMSL0BWYXIQbMBvH18BNjBFKyQR81ZW3qmQGC25WKoc533CpqoKXBrIyhxsmRc6MUCVUC6gNexRSmGcoylxk7l4u_5MMLlQNuTaiuPil0qw2rISVMkxrsS7gusx57UA11xpmymF-zOcuB5fcwNyFlvxMK27B9dDsRjv721OwXnCTrTyplq5eegf3xdEjYUtIa5vBBijs2yZNSN_FzUCRxTgJwyiKyBDjIQ1p31HbobaJo4jSnsRt3LaUTMH8l3v43H-c7Hjcvr2Mnd3tmne7P41blAZpgilFiHwDZI1iPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808729911</pqid></control><display><type>article</type><title>RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Mohammed, Amna B W E ; Rudwan, Elsadig H</creator><creatorcontrib>Mohammed, Amna B W E ; Rudwan, Elsadig H</creatorcontrib><description>Losartan potassium, a highly effective blood pressure lowering agent, has widely used for treatment of hypertension. Simple, economic, selective, and precise and stability indicating HPLC method has been developed and validated for analysis of losartan potassium in bulk drug and formulation dosage form. In order to optimize more one response at time, the chemo metric approach which includes 2 super( 3) factorial design at two level with three factors was set up to standardize the chromatographic condition. The mobile phase was 40:60 ACN: Buffer consist of 0.05% of orthophosphoric acid and 0.05% Triethylamine at flow rate 1.0ml/minute the eluent was monitored at 225nm. The calibration plots constructed using the concentration of 6.4 to 9.6 mu g/ml (80-120%) with r super( 2) =0.999, recovery =99.44% was indicative of accuracy of proposed method. The precision was calculated as repeatability, intraday for the drug.</description><identifier>EISSN: 0975-8232</identifier><identifier>DOI: 10.13040/IJPSR.0975-8232.7(6).2343-51</identifier><language>eng</language><ispartof>International journal of pharmaceutical sciences and research, 2016-06, Vol.7 (6), p.2343-2343</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Mohammed, Amna B W E</creatorcontrib><creatorcontrib>Rudwan, Elsadig H</creatorcontrib><title>RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM</title><title>International journal of pharmaceutical sciences and research</title><description>Losartan potassium, a highly effective blood pressure lowering agent, has widely used for treatment of hypertension. Simple, economic, selective, and precise and stability indicating HPLC method has been developed and validated for analysis of losartan potassium in bulk drug and formulation dosage form. In order to optimize more one response at time, the chemo metric approach which includes 2 super( 3) factorial design at two level with three factors was set up to standardize the chromatographic condition. The mobile phase was 40:60 ACN: Buffer consist of 0.05% of orthophosphoric acid and 0.05% Triethylamine at flow rate 1.0ml/minute the eluent was monitored at 225nm. The calibration plots constructed using the concentration of 6.4 to 9.6 mu g/ml (80-120%) with r super( 2) =0.999, recovery =99.44% was indicative of accuracy of proposed method. The precision was calculated as repeatability, intraday for the drug.</description><issn>0975-8232</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNo9j8tOwzAQRS0kJKrSf_AGqSwSYjsvL03itkZOHMVuJVZVHo4EKrSQ9nP4V1wenc1Ic-89VwPAHQp8RIIweBBPla79gCaRl2KC_WQe3_uYhMSL0BWYXIQbMBvH18BNjBFKyQR81ZW3qmQGC25WKoc533CpqoKXBrIyhxsmRc6MUCVUC6gNexRSmGcoylxk7l4u_5MMLlQNuTaiuPil0qw2rISVMkxrsS7gusx57UA11xpmymF-zOcuB5fcwNyFlvxMK27B9dDsRjv721OwXnCTrTyplq5eegf3xdEjYUtIa5vBBijs2yZNSN_FzUCRxTgJwyiKyBDjIQ1p31HbobaJo4jSnsRt3LaUTMH8l3v43H-c7Hjcvr2Mnd3tmne7P41blAZpgilFiHwDZI1iPg</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Mohammed, Amna B W E</creator><creator>Rudwan, Elsadig H</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160601</creationdate><title>RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM</title><author>Mohammed, Amna B W E ; Rudwan, Elsadig H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p118t-34b33beafe014dba873dc6af91e227445553f62f849dc9ec1ba65599d36b6bb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Mohammed, Amna B W E</creatorcontrib><creatorcontrib>Rudwan, Elsadig H</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of pharmaceutical sciences and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohammed, Amna B W E</au><au>Rudwan, Elsadig H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM</atitle><jtitle>International journal of pharmaceutical sciences and research</jtitle><date>2016-06-01</date><risdate>2016</risdate><volume>7</volume><issue>6</issue><spage>2343</spage><epage>2343</epage><pages>2343-2343</pages><eissn>0975-8232</eissn><abstract>Losartan potassium, a highly effective blood pressure lowering agent, has widely used for treatment of hypertension. Simple, economic, selective, and precise and stability indicating HPLC method has been developed and validated for analysis of losartan potassium in bulk drug and formulation dosage form. In order to optimize more one response at time, the chemo metric approach which includes 2 super( 3) factorial design at two level with three factors was set up to standardize the chromatographic condition. The mobile phase was 40:60 ACN: Buffer consist of 0.05% of orthophosphoric acid and 0.05% Triethylamine at flow rate 1.0ml/minute the eluent was monitored at 225nm. The calibration plots constructed using the concentration of 6.4 to 9.6 mu g/ml (80-120%) with r super( 2) =0.999, recovery =99.44% was indicative of accuracy of proposed method. The precision was calculated as repeatability, intraday for the drug.</abstract><doi>10.13040/IJPSR.0975-8232.7(6).2343-51</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 0975-8232
ispartof International journal of pharmaceutical sciences and research, 2016-06, Vol.7 (6), p.2343-2343
issn 0975-8232
language eng
recordid cdi_proquest_miscellaneous_1808729911
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD A FOR ESTIMATION OF LOSARTAN POTASSIUM UNDER STRESS CONDITION AND TABLET DOSAGE FORM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RP-HPLC%20METHOD%20DEVELOPMENT%20AND%20VALIDATION%20OF%20STABILITY%20INDICATING%20METHOD%20A%20FOR%20ESTIMATION%20OF%20LOSARTAN%20POTASSIUM%20UNDER%20STRESS%20CONDITION%20AND%20TABLET%20DOSAGE%20FORM&rft.jtitle=International%20journal%20of%20pharmaceutical%20sciences%20and%20research&rft.au=Mohammed,%20Amna%20B%20W%20E&rft.date=2016-06-01&rft.volume=7&rft.issue=6&rft.spage=2343&rft.epage=2343&rft.pages=2343-2343&rft.eissn=0975-8232&rft_id=info:doi/10.13040/IJPSR.0975-8232.7(6).2343-51&rft_dat=%3Cproquest%3E1808729911%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808729911&rft_id=info:pmid/&rfr_iscdi=true